Cyanotic heart defect medical therapy: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Cyanotic heart defect}} '''For patient information, click Cyanotic congenital heart disease''' {{CMG}..." |
No edit summary |
||
| (4 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Cyanotic heart defect}} | {{Cyanotic heart defect}} | ||
{{CMG}} | {{CMG}} | ||
'''Associate Editor(s)-In-Chief:''' [[User:KeriShafer|Keri Shafer, M.D.]] [mailto:kshafer@bidmc.harvard.edu], Atif Mohammad, M.D. | '''Associate Editor(s)-In-Chief:''' [[User:KeriShafer|Keri Shafer, M.D.]] [mailto:kshafer@bidmc.harvard.edu], Atif Mohammad, M.D.; {{KD}} | ||
==Overview== | ==Overview== | ||
| Line 12: | Line 10: | ||
==Medical Therapy== | ==Medical Therapy== | ||
Infants that remain in the hospital may receive medicines to: | Infants that remain in the hospital may receive medicines to: | ||
*Get rid of extra fluids | *Get rid of extra fluids | ||
*Help the heart pump harder | *Help the heart pump harder | ||
*Treat abnormal heartbeats or rhythms | *Treat abnormal heartbeats or rhythms | ||
* Prostaglandin E1 (alprostadil) — Administered in infants with clinical suspicion of ductal-dependent congenital heart defect until a definitive diagnosis or treatment is established. | |||
==References== | ==References== | ||
Latest revision as of 22:03, 18 October 2012
|
Cyanotic heart defect Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cyanotic heart defect medical therapy On the Web |
|
American Roentgen Ray Society Images of Cyanotic heart defect medical therapy |
|
Risk calculators and risk factors for Cyanotic heart defect medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Associate Editor(s)-In-Chief: Keri Shafer, M.D. [2], Atif Mohammad, M.D.; Kalsang Dolma, M.B.B.S.[3]
Overview
Medical Therapy
Infants that remain in the hospital may receive medicines to:
- Get rid of extra fluids
- Help the heart pump harder
- Treat abnormal heartbeats or rhythms
- Prostaglandin E1 (alprostadil) — Administered in infants with clinical suspicion of ductal-dependent congenital heart defect until a definitive diagnosis or treatment is established.